Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0
- Conditions
- Premature EjaculationCognitive-Behavior TreatmentMasturbation Aid Device
- Registration Number
- NCT03304808
- Lead Sponsor
- Instituto Sexológico Murciano
- Brief Summary
The present study included 57 patients ≥18 years who met diagnostic criteria for PE including intravaginal ejaculatory latency time (IELT) of ≤2 minutes and had a Premature Ejaculation Diagnostic Tool (PEDT) score ≥11.
Subjects were randomized to an experimental group that used the device with exercise programme (n=18) a first control group that only used the exercise programme (n=17) and a wait-list control group (n=22).
As a main outcome measure used stopwatch-measured average IELT, Premature Ejaculation Profile (PEP), and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 35
- Participants must be heterosexual males
- To be in a stable monogamous, sexual relationship with a female partner for at least 6 months,
- Must score = 11 in the Premature Ejaculation Diagnostic Tool (PEDT).
- Must have a self-estimated average intravaginal ejaculatory latency time (IELT) of <2 min. -Must be in good general health with no clinically significant abnormalities as determined by medical history and clinical lab results.
- To suffer an alteration or mental disorder according to the criteria of the DSM-IV.
- History of alcohol abuse and dependence.
- Do not to consume medication, drugs of recreative use or alcohol (except for caffeine or nicotine/tobacco).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method IELT FOLD INCREASE 7 weeks fold changes are defined directly in terms of ratios.If the initial value is A and the final value B, the fold change is defined as B/A
- Secondary Outcome Measures
Name Time Method Premature Ejaculation Profile (PEP) 7 weeks proportion of patients who achieved criteria for clinical benefit, defined as achieving a two-category or greater increase in the change in control over ejaculation and level of satisfaction with intercourse, and a one-category or greater increase in the change in ejaculation-related distress and degree of interpersonal difficulty.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Jesús Rodríguez
🇪🇸Murcia, Spain
Jesús Rodríguez🇪🇸Murcia, Spain